CClinicalTrials.gg
CompletedNCT07493200Updated Oct 5, 2026

The Effect of Earplugs on Gag Reflex and Patient Comfort in Root Canal Treatment

An interventional study of Custom-Made Silicone Earplug in Gag Reflex, sponsored by Beyhan Başkan. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Beyhan Başkan · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled May 2025, registered Mar 2026).
Updated Oct 5, 2026Now CompletedStudy completion moved+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluated whether wearing an earplug during root canal treatment reduces the gag reflex and the stress it causes. Forty adults who had a severe or very severe gag reflex were randomly divided into two groups. One group received an earplug in the ear opposite to the side being treated; the other group received standard treatment without an earplug. The severity of the gag reflex was scored by an observer, stress was measured using a saliva sample (salivary alpha-amylase), and treatment time and gag-related interruptions were recorded. The results showed that the earplug group had lower gag-reflex scores, lower stress levels, and shorter treatment times with fewer interruptions. No side effects were reported. These findings suggest that a simple, low-cost earplug may help patients who gag easily during dental treatment.

Read the detailed description

Background: An exaggerated gag reflex is a common problem during dental treatment, especially in endodontics, where uninterrupted working time and moisture control are essential. Pharmacological approaches carry risks, and evidence for non-pharmacological methods is limited. Earplug stimulation of the external auditory canal has been proposed as a simple, non-invasive way to suppress the gag reflex.

Objective: To evaluate the effect of earplug application during endodontic treatment on gag-reflex severity, physiological stress (salivary alpha-amylase, sAA), and clinical efficiency (treatment time and gag-related interruption ratio).

Methods: This prospective, randomized controlled trial enrolled 40 adults with severe or very severe gagging (Dickinson-Fiske Gagging Severity Index grade 4-5) requiring endodontic treatment. Participants were randomly allocated 1:1 to an earplug group or a control group. A custom-moulded silicone earplug was placed in the ear contralateral to the operating field. The operator and the outcome assessor were blinded by an identical adhesive ear cover applied to all participants; participants could not be blinded. Gag-reflex severity was scored with an 8-item behavioural scale (0-8). Unstimulated whole saliva was collected before and after treatment for sAA measurement. Total treatment time and gag-related interruption time were recorded, and the interruption ratio was calculated as (interruption time / total treatment time) × 100. Non-parametric tests and baseline-adjusted ANCOVA on log-transformed sAA were used.

Results: The earplug group had a lower behavioural gag-reflex score (median 3.0 vs 5.5; p \< 0.01) and a more favourable severity distribution (trend p \< 0.01). sAA decreased after treatment with the earplug but increased in controls (median change -31.8% vs +76.2%); baseline-adjusted post-treatment sAA was 59% lower with earplug use (geometric mean ratio 0.41, 95% CI 0.32-0.53; p \< 0.001). Treatment time and the interruption ratio were markedly lower with earplug use (both p \< 0.001). No adverse effects were observed.

Conclusions: Earplug application during endodontic treatment was associated with reduced gag-reflex severity, an attenuated physiological stress response, and improved procedural efficiency. As a simple, inexpensive, non-invasive technique, the earplug may be a useful adjunct for managing severe gagging in endodontic practice. Larger, multi-centre trials with patient-reported outcomes are warranted.

Trial registration: ClinicalTrials.gov, NCT07493200.

02

Conditions studied

  • Gag Reflex

Keywords

  • Salivary Alpha-Amylase
  • Root Canal Treatment
  • Randomized Controlled Trial
03

In context

Lead sponsor

This is the only study on the registry with Beyhan Başkan as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Age over 18 years Need for endodontic treatment Score of 4 (severe gagging: occurs with all forms of treatment) or 5 (very severe gagging: makes treatment impossible) on the Dickinson and Fiske Gagging Severity Index (GSI)

Exclusion criteria

Exclusion Criteria:

Systemic disease Pregnancy or lactation Diagnosed central or peripheral nervous system disorders Use of anti-emetic medication Ear infection or structural abnormality of the external auditory canal

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Experimental Group

    Patients in this group (n=20) will have a custom-made silicone earplug placed in the ear opposite the side where the dentist is working during their root canal treatment. The earplug is fabricated immediately before the procedure using soft silicone material to ensure a comfortable, personalized fit. No other pharmacological or behavioral interventions for gag reflex control will be used.

    Device: Custom-Made Silicone Earplug

  • No intervention
    Control Group

    Patients in this group (n=20) will receive standard root canal treatment without any earplug placement. No interventions for gag reflex control will be used. All outcome measures (gag reflex severity, behavioral responses, treatment pause ratio, salivary alpha-amylase) will be collected in the same manner as for the experimental group.

Interventions

  • DeviceCustom-Made Silicone Earplug

    A personalized earplug fabricated from a soft, two-component addition-cure silicone (C-type silicone), commonly used for dental impressions. The two components are mixed according to the manufacturer's instructions and gently injected into the patient's external auditory canal on the side contralateral to the tooth receiving treatment. The silicone is allowed to polymerize for approximately 2-3 minutes, creating a custom-fit plug that conforms precisely to the individual contours of the ear canal. This ensures comfortable, continuous, and gentle tactile stimulation to the walls of the ear canal throughout the entire root canal procedure. The earplug is removed at the end of the treatment and is for single-patient use only. No other devices or pharmacological agents are used in conjunction with this intervention.

06

What researchers measure

Primary outcomes

  1. Behavioural Gag-Reflex Score

    An 8-item behavioural observation scale (0-8) was used to quantify the intraoperative gag response. One point was assigned for each of: eye-squeezing, sweating, physical contraction, withdrawal, groaning, crying, breath-holding, and increased salivation. The total score was categorised as Mild (0-2), Moderate (3-4), Severe (5-6), or Very Severe (7-8).

    Time frame: Throughout the root canal procedure (continuous observation by a blinded assessor)

Secondary outcomes

  1. Behavioural Gag-Reflex Severity Distribution

    The total 8-item behavioural score (0-8) was categorised as Mild (0-2), Moderate (3-4), Severe (5-6), or Very Severe (7-8). The distribution of these categories after treatment was compared between groups using the Cochran-Armitage trend test.

    Time frame: Throughout the root canal procedure

  2. Gag-Related Interruption Ratio

    The cumulative duration of gag-related pauses was divided by total treatment time and multiplied by 100. Total treatment time was measured from the start of access-cavity preparation to completion of the root-canal filling.

    Time frame: Throughout the procedure

  3. Salivary α-Amylase Activity

    Unstimulated whole saliva was collected before and after treatment, centrifuged (10,000 × g, 10 min, 4 °C), and stored at -80 °C. sAA activity was measured colorimetrically using a commercial kit (Elabscience, Cat. No. E-BC-K007-M) based on the DNS method; optical density was read at 540 nm.

    Time frame: Immediately before and immediately after the procedure

  4. Total Treatment Time

    Time from start of access-cavity preparation to completion of root-canal filling, measured with a digital stopwatch.

    Time frame: Throughout the procedure

07

Study locations

1 site
  • Kahramanmaraş Sütçü İmam Universty
    Kahramanmaraş, 46140, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (demographic, behavioural, salivary α-amylase, and procedural time data) will be shared. Requests should be directed to the corresponding author.

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Active, not recruiting→Completed
changed Oct 5, 2026
Study completion
Apr 30, 2026→Feb 5, 2026 (actual)
Oct 5, 2026
Also revised
eligibility and primary outcomes
Show all 1 update
  1. Oct 5, 2026
    Active, not recruiting→Completed
    Study completion Apr 30, 2026→Feb 5, 2026 (now actual)
    Eligibility Criteria revised
    Primary outcomes Revised (2 changes)
    + 7 other changes: identifiers, verification date, description, design details, secondary outcomes, references and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07493200
Lead sponsor
Beyhan Başkan
Responsible party
Beyhan Başkan (Assistant Professor, Kahramanmaras Sutcu Imam University) — Sponsor-investigator
First posted
Mar 25, 2026
Start date
May 12, 2025
Primary completion
Feb 5, 2026
Completion
Feb 5, 2026
Last update
Oct 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion